Yawei Li

发表

Systematic exploration of the underlying mechanism of gemcitabine resistance in pancreatic adenocarcinoma

Ting Chen, Yunyan Gu, Min Zou, 2022, Molecular oncology.

Upregulation of CXCL1 and LY9 contributes to BRCAness in ovarian cancer and mediates response to PARPi and immune checkpoint blockade

Ting Chen, Yunyan Gu, Yan Xu, 2022, British Journal of Cancer.

A genetic map of the chromatin regulators to drug response in cancer cells

Ting Chen, Yunyan Gu, Min Zou, 2022, Journal of Translational Medicine.

Individualized lncRNA differential expression profile reveals heterogeneity of breast cancer

Xia Li, Yunyan Gu, Lichun Sun, 2021, Oncogene.

Revealing biomarkers associated with PARP inhibitors based on genetic interactions in cancer genome

Yunyan Gu, L. Qi, Haihai Liang, 2021, Computational and structural biotechnology journal.

A transcriptional signature detects homologous recombination deficiency in pancreatic cancer at the individual level

Ting Chen, Yunyan Gu, Zhiqiang Chang, 2021, Molecular Therapy. Nucleic Acids.

Discovering a qualitative transcriptional signature of homologous recombination defectiveness for prostate cancer

Xia Li, Yunyan Gu, Min Zou, 2021, iScience.

Individualized detection of TMPRSS2-ERG fusion status in prostate cancer: a rank-based qualitative transcriptome signature

Yunyan Gu, Zhangxiang Zhao, Kaidong Liu, 2024, World journal of surgical oncology.

Multi-omics integration analysis unveils heterogeneity in breast cancer at the individual level

Yunyan Gu, Tongzhu Jin, Zhangxiang Zhao, 2023, Cell cycle.